February 27 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that Moldova's competition regulator has allowed it to acquire Moldovan pharmaceutical company RAP Pharma International.
"Moldova's competition regulator has granted its approval to Sopharma to acquire 51% of RAP Pharma International's capital," Sopharma said in a bourse filing on the Bulgarian stock exchange.
You can subscribe to our M&A newsletter here
According to data from the Moldovan commercial registry, RAP Pharma International is 80% owned by Molfarm SRL, as individual investor Victor Alergus holds the remainder.
This is the latest in a series of acquisitions which Sopharma undertook lately.
Earlier this month it filed for regulatory approval for the acquisition of a stake in Bulgaria's Doverie United Holding, in which it holds over 25%.
In November, Sopharma acquired 68% of local drug producer Veta Pharma.
Sopharma shares closed 2.96% higher on Monday at 3.480 levs ($1.88/1.77 euro) as 84 shares changed hands on the BSE.
(1 euro = 1.95583 levs)